Astrocytes as targets for drug discovery
- PMID: 29317338
- PMCID: PMC5937927
- DOI: 10.1016/j.drudis.2018.01.011
Astrocytes as targets for drug discovery
Abstract
Recent studies have illuminated the crucial role of astrocytes in maintaining proper neuronal health and function. Abnormalities in astrocytic functions have now been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). Historically, drug development programs for neurodegenerative diseases generally target only neurons, overlooking the contributions of astrocytes. Therefore, targeting both disease neurons and astrocytes offers a new approach for drug development for the treatment of neurological diseases. Looking forward, the co-culturing of human neurons with astrocytes could be the next evolutionary step in drug discovery for neurodegenerative diseases.
Published by Elsevier Ltd.
Figures
Similar articles
-
Astrocytes in neurodegenerative disease.Cold Spring Harb Perspect Biol. 2015 Apr 15;7(6):a020628. doi: 10.1101/cshperspect.a020628. Cold Spring Harb Perspect Biol. 2015. PMID: 25877220 Free PMC article. Review.
-
Astrocytes: From the Physiology to the Disease.Curr Alzheimer Res. 2019;16(8):675-698. doi: 10.2174/1567205016666190830110152. Curr Alzheimer Res. 2019. PMID: 31470787 Review.
-
Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases.Curr Pharm Des. 2015;21(25):3570-81. doi: 10.2174/1381612821666150710144502. Curr Pharm Des. 2015. PMID: 26166612 Review.
-
High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.Stem Cells Transl Med. 2016 May;5(5):613-27. doi: 10.5966/sctm.2015-0170. Epub 2016 Mar 31. Stem Cells Transl Med. 2016. PMID: 27034412 Free PMC article.
-
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019. PLoS One. 2019. PMID: 30897183 Free PMC article.
Cited by
-
Roles of Astrocytic Endothelin ETB Receptor in Traumatic Brain Injury.Cells. 2023 Feb 24;12(5):719. doi: 10.3390/cells12050719. Cells. 2023. PMID: 36899860 Free PMC article. Review.
-
A combined use of silver pretreatment and impregnation with consequent Nissl staining for cortex and striatum architectonics study.Front Neuroanat. 2022 Oct 14;16:940993. doi: 10.3389/fnana.2022.940993. eCollection 2022. Front Neuroanat. 2022. PMID: 36312299 Free PMC article.
-
Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.Redox Biol. 2020 Sep;36:101664. doi: 10.1016/j.redox.2020.101664. Epub 2020 Aug 1. Redox Biol. 2020. PMID: 32863224 Free PMC article. Review.
-
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease.J Neuroinflammation. 2020 Apr 6;17(1):105. doi: 10.1186/s12974-020-01791-8. J Neuroinflammation. 2020. PMID: 32252767 Free PMC article.
-
A Focus on Astrocyte Contribution to Parkinson's Disease Etiology.Biomolecules. 2022 Nov 24;12(12):1745. doi: 10.3390/biom12121745. Biomolecules. 2022. PMID: 36551173 Free PMC article. Review.
References
-
- Azevedo F, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 2009;513:532–541. - PubMed
-
- Taft JR, et al. Distribution of GFAP+ astrocytes in adult and neonatal rat brain. Int. J. Neurosci. 2005;115:1333–1343. - PubMed
-
- Zheng Y, Barres B. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010;20:588–594. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous